1	participant must either be aed therapy na?ve or on an aed excluding benzodiazepine for 1-week or less child may be on a stable dose of psychostimulants at the time of enrollment but no change in medication dose or schedule in 3 month prior to study enrollment with no anticipate dose change during|na[39,41]||||||||||56501|56501|na m-fluorphosphate
1	participant must either be aed therapy na?ve or on an aed excluding benzodiazepine for 1-week or less child may be on a stable dose of psychostimulants at the time of enrollment but no change in medication dose or schedule in 3 month prior to study enrollment with no anticipate dose change during|benzodiazepine[68,82]||||||||||1402|1402|benzodiazepine
1	participant must either be aed therapy na?ve or on an aed excluding benzodiazepine for 1-week or less child may be on a stable dose of psychostimulants at the time of enrollment but no change in medication dose or schedule in 3 month prior to study enrollment with no anticipate dose change during|psychostimulants[135,151]|||||||3 month[226,233]||C3653645|1430810|1430810|psychostimulants
2	the 6 month of the study if participant be take psychostimulants at the time of study entry they should plan on continue them for the 6 month duration of the study protocol include the 3-month and 6-month cognitive and behavioral testing time point|psychostimulants[346,362]|||||||6 month[302,309]||C3653645|1430810|1430810|psychostimulants
